<?xml version="1.0" encoding="UTF-8"?>
<p id="par0095">A trial of tetrandrine tablets which were used in our research, for COVID-19 treatment, is registered at ClinicalTrials.gov (
 <ext-link ext-link-type="uri" xlink:href="https://www.clinicaltrials.gov/" id="intr0005" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.clinicaltrials.gov/</ext-link>) and it focuses on reduction of inflammations, including pneumonia, due to the anti-inflammatory effect of tetrandrine, rather than the antiviral effect itself.
 <xref rid="bib0070" ref-type="bibr">
  <sup>14</sup>
 </xref>
</p>
